Literature DB >> 9214306

Folding of tryptophan mutants of barstar: evidence for an initial hydrophobic collapse on the folding pathway.

U Nath1, J B Udgaonkar.   

Abstract

The contributions of the three tryptophan residues of barstar to the spectroscopic properties, stability, and folding of the protein have been studied by mutating two of the tryptophans, Trp38 and Trp44, individually as well as together, to phenylalanines, Phe. The three mutant proteins studied are shown to be similar to wt barstar in structure by activity measurements as well as by spectroscopic characterization. Fluorescence energy transfer between the tryptophans as well as quenching by their local structural environments complicates the analysis of the contributions of the individual tryptophans to the fluorescence of the wt protein, but it is demonstrated that Trp53, which is completely buried within the hydrophobic core, makes the dominant contribution to the fluorescence, while the fluorescence of Trp38 is largely quenched in the fully folded protein. GdnHCl- as well as temperature-induced equilibrium unfolding studies, using three different structural probes, indicate that W38FW44F, where both Trp38 and Trp44 have been removed, follows a two-state unfolding transition and is less stable than the wt barstar. The fluorescence-monitored folding and unfolding kinetics of W38FW44F have been studied in detail. W38FW44F folds 2-fold faster and unfolds 3-fold faster than wt barstar. A large fraction of the total fluorescence change that occurs during folding occurs in a burst phase within 4 ms after commencement of folding. A similar burst phase change in fluorescence, although to a smaller extent, is shown to occur during the folding of wt barstar. The results suggest that a very early folding intermediate accumulates within 4 ms of folding, and that this kinetic intermediate is sufficiently compact that Trp53, which is completely sequestered from solvent in the fully folded protein, is also significantly sequestered from solvent in this intermediate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9214306     DOI: 10.1021/bi970426z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Folding of barstar C40A/C82A/P27A and catalysis of the peptidyl-prolyl cis/trans isomerization by human cytosolic cyclophilin (Cyp18).

Authors:  R Golbik; G Fischer; A R Fersht
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

2.  Proteins with beta-(thienopyrrolyl)alanines as alternative chromophores and pharmaceutically active amino acids.

Authors:  N Budisa; S Alefelder; J H Bae; R Golbik; C Minks; R Huber; L Moroder
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

3.  Unfolding of a small protein proceeds via dry and wet globules and a solvated transition state.

Authors:  Saswata Sankar Sarkar; Jayant B Udgaonkar; Guruswamy Krishnamoorthy
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

4.  Association and activation of fructose 1,6-bisphosphase during unfolding and refolding: spectroscopic and enzymatic studies.

Authors:  C Yuan; Z Q Xie; F W Zhang; G J Xu
Journal:  J Protein Chem       Date:  2001-01

5.  Tryptophan fluorescence reveals the presence of long-range interactions in the denatured state of ribonuclease Sa.

Authors:  Roy W Alston; Mauricio Lasagna; Gerald R Grimsley; J Martin Scholtz; Gregory D Reinhart; C Nick Pace
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

6.  The Folding process of Human Profilin-1, a novel protein associated with familial amyotrophic lateral sclerosis.

Authors:  Edoardo Del Poggetto; Fabrizio Chiti; Francesco Bemporad
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

7.  Refolding of Cold-Denatured Barstar Induced by Radio-Frequency Heating: A New Method to Study Protein Folding by Real-Time NMR Spectroscopy.

Authors:  György Pintér; Harald Schwalbe
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-25       Impact factor: 15.336

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.